CPD Events


Canine and Feline Oncology

Date : Wednesday 17th July 2019
Venue : Huthard Room II & Presidents Room, 3/F South Tower, YMCA, 41 Salisbury Road, Tsim Sha Tsui (http://www.ymcahk.org.hk)
Time : Registration & Buffet Dinner: 7:00~8:00 pm, Seminar: 8:00~10:30 pm
Speaker : Professor David Argyle

Early Bird Registration :
(before 11:30pm of 16 Jul 2019)
  • Include Dinner
    • Members : $480
    • Non-Members : $750
    • CPD Hours : 2.5

Extended Registration and On-site Registration :
  • Include Dinner
    • Members : $1000
    • Non-Members : $1000
    • CPD Hours : 2.5

Organizer : The Hong Kong Veterinary Association Ltd.

Decision Making in Canine and Feline Skin Tumours
Skin Cancer is a major disease of dogs and cats. In dogs skin cancer is the most common tumour type (1/3 of all tumours, with 30% being malignant). In cats they account for the second most common tumour type, accounting for around 25% of all reported neoplasms. Compared to dogs (who demonstrate significantly higher numbers of benign skin masses), around 65-70% of skin masses in cats are malignant. In this lecture, Professor Argyle will explore the most recent thinking and advances in the management of skin cancer in dogs and cats, including preventative measures. There will be a focus on the most common cancer types, including mast cell disease and squamous carcinoma and exploration of more complex syndromes such as histiocytic disease and epitheliotropic lymphoma.

Update on Canine and Feline Lymphoma
Lymphoma is one of the commonest forms of malignancy encountered in small animal practice. It is characterised by the malignant proliferation of lymphoid cells which can arise in any organ containing lymphoid tissue. Lymphoma (syn. malignant lymphoma, lymphosarcoma) is one of the more common canine neoplasms. In cats, FeLV remains the commonest cause of lymphoma. In this lecture, Professor Argyle will explore the recent thinking on Lymphoma with reference to new approaches to diagnosis, and some of the new drugs that are now available or in development.


Speakers' biography


Professor David Argyle
BVMS PhD DECVIM-CA (Oncology) FRSE FRCVS

David Argyle graduated from the University of Glasgow Veterinary School and subsequently worked in general practice. He returned to Glasgow to complete a PhD in the department of Veterinary Pathology and then worked as a lecturer and senior lecturer in clinical oncology in the Department of Clinical Studies. In 2002, he became Associate Professor of Clinical Oncology at the University of Wisconsin-Madison, USA. In 2005, he returned to the UK to take the William Dick Chair of Clinical Studies at the University of Edinburgh. On his return he set up the R(D)SVS Cancer and Imaging Centre. He in an RCVS and European Specialist in Veterinary Oncology, a Diplomat of the European College of Internal Medicine in Oncology, and is co-scientific editor of the Journal of Veterinary and Comparative Oncology. Within the R(D)SVS, he is the Dean of Veterinary Medicine and Head of School, and is also the Deputy Head of The College of Medicine and Veterinary Medicine. He has overall responsibility for the School including its research arm, the Roslin Institute. In 2016, he was elected Fellow of the Royal Society of Edinburgh. In the same year he was elected Fellow of the Royal College of Veterinary Surgeons (for meritorious contributions to veterinary research).


Hope to see you there.
Howie Wong
HKVA CPD Coordinators

For enquiries please email secretariat@medcom.com.hk



Back